K. S. Cathcart

535 total citations
9 papers, 441 citations indexed

About

K. S. Cathcart is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, K. S. Cathcart has authored 9 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 2 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in K. S. Cathcart's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Pneumonia and Respiratory Infections (2 papers). K. S. Cathcart is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Pneumonia and Respiratory Infections (2 papers). K. S. Cathcart collaborates with scholars based in United States. K. S. Cathcart's co-authors include Gary Peters, Paul A. Bombardt, Joseph C. Fleishaker, Kenneth L. Feenstra, Linda D. Compton, David Baker, Laura Pearson, Larry J. Schaaf, J. Greg Slatter and Langdon L. Miller and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Drug Metabolism and Disposition and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

K. S. Cathcart

9 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. S. Cathcart United States 9 206 157 130 46 46 9 441
Paul A. Bombardt United States 9 200 1.0× 156 1.0× 91 0.7× 19 0.4× 21 0.5× 13 404
B N Swanson United States 8 120 0.6× 66 0.4× 155 1.2× 7 0.2× 66 1.4× 10 378
Peter Tobin Australia 8 207 1.0× 191 1.2× 39 0.3× 27 0.6× 17 0.4× 11 421
Takehiro Hagiwara Japan 7 423 2.1× 292 1.9× 85 0.7× 19 0.4× 33 0.7× 9 567
Carole Marbeuf‐Gueye France 9 179 0.9× 234 1.5× 24 0.2× 14 0.3× 47 1.0× 14 426
Stuart Mair United Kingdom 13 89 0.4× 114 0.7× 107 0.8× 8 0.2× 50 1.1× 27 415
Qianzhou Lv China 13 112 0.5× 54 0.3× 75 0.6× 12 0.3× 94 2.0× 41 428
Kyung Im Kim South Korea 12 76 0.4× 67 0.4× 38 0.3× 27 0.6× 8 0.2× 25 381
Aihua Bao China 14 186 0.9× 44 0.3× 42 0.3× 27 0.6× 52 1.1× 30 538
Edyta Szałek Poland 12 114 0.6× 90 0.6× 93 0.7× 3 0.1× 36 0.8× 67 415

Countries citing papers authored by K. S. Cathcart

Since Specialization
Citations

This map shows the geographic impact of K. S. Cathcart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. S. Cathcart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. S. Cathcart more than expected).

Fields of papers citing papers by K. S. Cathcart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. S. Cathcart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. S. Cathcart. The network helps show where K. S. Cathcart may publish in the future.

Co-authorship network of co-authors of K. S. Cathcart

This figure shows the co-authorship network connecting the top 25 collaborators of K. S. Cathcart. A scholar is included among the top collaborators of K. S. Cathcart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. S. Cathcart. K. S. Cathcart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Slatter, J. Greg, Larry J. Schaaf, James P. Sams, et al.. (2000). Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients. Drug Metabolism and Disposition. 28(4). 423–433. 241 indexed citations
2.
Fleishaker, Joseph C., Gary Peters, & K. S. Cathcart. (1993). Evaluation of the Pharmacokinetics and Tolerability of Tirilazad Mesylate, a 21‐Aminosteroid Free Radical Scavenger: I. Single‐Dose Administration. The Journal of Clinical Pharmacology. 33(2). 175–181. 52 indexed citations
3.
Fleishaker, Joseph C., Gary Peters, K. S. Cathcart, & Rick C. Steenwyk. (1993). Evaluation of the Pharmacokinetics and Tolerability of Tirilazad Mesylate, a 21‐Aminosteroid Free Radical Scavenger: II. Multiple‐Dose Administration. The Journal of Clinical Pharmacology. 33(2). 182–190. 28 indexed citations
4.
Borin, Marie T., et al.. (1991). Pharmacokinetic and Tolerance Studies of Cefpodoxime after Single‐ and Multiple‐Dose Oral Administration of Cefpodoxime Proxetil. The Journal of Clinical Pharmacology. 31(12). 1137–1145. 27 indexed citations
5.
Steenwyk, Rick C., et al.. (1991). Reversed-Liquid Phase Chromatographic Determination of Cefpodoxime in Human Plasma. Journal of Liquid Chromatography. 14(20). 3641–3656. 23 indexed citations
6.
Bombardt, Paul A., et al.. (1991). Determination of Cefpodoxime Levels and Cefpodoxime Stability In Human Urine By Direct Injection HPLC with Column-Switching. Journal of Liquid Chromatography. 14(9). 1729–1746. 18 indexed citations
7.
Halstenson, C E, David R.P. Guay, John A. Opsahl, et al.. (1990). Disposition of cefmetazole in healthy volunteers and patients with impaired renal function. Antimicrobial Agents and Chemotherapy. 34(4). 519–523. 11 indexed citations
9.
Ko, Howard, et al.. (1989). Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination. Antimicrobial Agents and Chemotherapy. 33(3). 356–361. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026